Nanogen Opts to Close Microarray Business; Will Axe 20 Percent of Staff and Focus on RT-PCR | GenomeWeb
NEW YORK (GenomeWeb News) - Nanogen has ended two months of speculation about the future of its microarray business by saying it decided to shut down the unit, lay off around 20 percent of its staff, and realign the company behind its real-time PCR and point-of-care testing units, the firm said Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.